Printer FriendlyAbout Cure Cancer Australia

 
Cure Cancer Australia Foundation has been funding cancer and leukaemia research programs since it began 41 years ago having funded over 350 researchers.

With the generosity of everyone, the Foundation has been able to support some amazing research scientists at the start of their careers, a time when very little funding is available. This support enables Australia’s brightest research talent to secure further funding, build on their ideas and continue their vital work in Australia. The Foundation have funded grants across all areas of cancer research, including children’s cancers, breast, bowel, skin, prostate, thyroid and bladder cancers and leukaemia.

Thanks to all our donors, our mission is possible: to give young scientists the support they need to pursue potential breakthrough research and ultimately a cure.

Contribute to the cure.

How is Can Too connected to Cure Cancer Australia?

Cure Cancer Australia is proud to have been selected as Can Too’s partner. All of the money raised from Can Too participants goes directly to Cure Cancer Australia to fund cancer research projects. At this time (late 2008) Can Too participants have raised nearly $4,000,000 for Cure Cancer Australia. Each year, the funds raised for and/or by Cure Cancer Australia go directly to brilliant young researchers to enable them to pursue their potential breakthrough cancer research, for a period of one year. We are only able to achieve this due to the generosity of the Macquarie Bank Foundation, our Principal Supporter.

Can Too have funded the following researchers:

2005        Dr Megan Hitchins at St Vincents hospital for her research into bowel cancer

2006        Dr Matthew Naylor, Garvan Institute  of Medical Research:   Breast Cancer 
                Dr Kirsten Hammond, University of Sydney:  Skin Cancer 
                Dr Tao Liu, Childrens Cancer Institute of Australia:  Neuroblastoma in children 
                Dr Graham Ball, University  New South Wales:  New Drug design 
                Dr Megan Fabbro, Children’s Medical Research Institute:  Cell Division in Cancer

2007        Professor Maurice Eisenbruch, University of Sydney:  Breast Cancer and cross cultural communication about prognosis more
               Dr Susan Fanayan, Australian Proteome Analysis Facility, Macquarie University:  Understanding cancer behaviour using proteomic approaches         
               Dr Viive Howell, Kolling Institute of Medical Research:  Ovarian Cancer  
               Dr Toby Hulf, Garvan Institute of Medical Research:  Prostate Cancer 
               Dr Hugh Morgan, Royal North Shore Hospital/University of Sydney:  Control Mechanisms in Cancer
               Dr Ron Sluyter, University of Wollongong/University of Sydney:  Issues relating to blood clotting
               Dr Shane Thomas, University of New South Wales:  Strategies to inhibit cancer cell growth
               Dr Wayne Thomas, Children's Cancer Institute Australia:  Brain Tumours

2008        Dr Phoebe Phillips, University of NSW: Factors influencing the growth of pancreatic cancer    
               
Dr Jordan Malaterre, Peter MacCallum Cancer Centre: Protecting children’s brains against side-effects of radiotherapy treatment for cancer
               
Dr Vanessa Bonazzi, Queensland Institute of Medical Research: Finding more of the genes that normally protect against melanoma 
               
Dr Ulla Simanainen, ANZAC Research Inst.: Hormones that may protect against prostate cancer
               
Dr Ivan Ivetac, Peter MacCallum Cancer: A gene involved in breast & ovarian cancers
               
Dr Eleanor Ager, Austin Health: How bowel cancer spreads to the liver 
               
Dr Amber Alsop, Peter MacCallum Cancer: Finding improved treatments for leukaemia 


What type of projects does Cure Cancer Australia funding support?

Cure Cancer Australia raises funds through innovative fundraising and with the support of valued corporate and individual donors. To date, more than $8.9 million has been allocated to individual research projects at cancer research institutes, teaching hospitals and university medical faculties in New South Wales, Australia.

The researchers are based in Australia’s leading medical research institutes such as Children’s Cancer Institute Australia, Children’s Medical Research Institute, Garvan Institute of Medical Research, Centenary Institute, Westmead Millennium Institute, Kolling Institute of Medical Research as well as teaching hospitals and university medical faculties.

To read more about Cure Cancer Australia www.cure.org.au

Kolling Institute 

Supported by The Blue Arc Group